Know What's Happening in Industry

GPs to Get £3,000 Bonus to Maximise Weight Loss Drug Prescriptions

The UK government will add a £3,000 average annual bonus to GP contracts for prescribing the weight‑loss drug Mounjaro, plus a £1,000 incentive for referrals to weight‑loss programmes, starting in April 2026. The scheme targets patients who meet current NHS eligibility – initially a BMI over 40, widening to 35 next year – and aims to increase uptake of the injectable therapy. Critics argue the incentive does little to broaden access because prescription criteria remain tightly restricted. The policy seeks to shift NHS focus toward prevention, but may add to GP workload.